Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.

NCT06364267 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Tamoxifen 10 MG
DRUG: Exemestane 25 MG

Sponsor

Andrea DeCensi

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]